Results 11 to 20 of about 2,707,119 (197)

Factors involved in the decision to decline prenatal screening with noninvasive prenatal testing (NIPT) [PDF]

open access: yesPrenatal Diagnosis, 2022
AbstractObjectiveTo investigate factors involved in the decision to decline prenatal screening with noninvasive prenatal testing (NIPT).MethodA questionnaire study was conducted among 219 pregnant women in the Netherlands who had declined prenatal screening with NIPT (TRIDENT‐2 study).
Schuurman, Lisanne van Prooyen   +11 more
core   +8 more sources

Concordance analysis between noninvasive prenatal testing (NIPT) and prenatal karyotyping for detecting fetal aneuploidies

open access: yesRevista de la Facultad de Medicina, 2023
Introduction: Noninvasive prenatal testing (NIPT) is a screening test for fetal aneuploidy with higher specificity and sensibility rates compared to traditional biochemical prenatal screening. Objective: To evaluate concordance between NIPT and prenatal
Diana Carolina Grajales-Ospina   +5 more
doaj   +2 more sources

Detection of fetal trisomy 9 mosaicism by noninvasive prenatal testing through maternal plasma DNA sequencing

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2018
Objective: Noninvasive prenatal testing (NIPT) is widely used as a powerful screening tool to detect common aneuploidies. However, its application for detection of rare chromosomal abnormalities remains inconclusive.
Chung-Yuan Lee   +8 more
doaj   +2 more sources

Factors involved in the decision to decline prenatal screening with noninvasive prenatal testing (NIPT) [PDF]

open access: yes, 2023
OBJECTIVE: To investigate factors involved in the decision to decline prenatal screening with noninvasive prenatal testing (NIPT). METHOD: A questionnaire study was conducted among 219 pregnant women in the Netherlands who had declined prenatal screening with NIPT (TRIDENT-2 study).
Dutch NIPT Consortium   +2 more
openaire   +2 more sources

From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan [PDF]

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2013
Down syndrome is the most common autosomal chromosome aneuploidy. The prenatal Down syndrome screening protocol has been known in Taiwan for the past 20 years.
S.W. Steven Shaw   +2 more
doaj   +2 more sources

Non-invasive prenatal testing: a review of international implementation and challenges

open access: yesInternational Journal of Women's Health, 2015
Megan Allyse,1 Mollie A Minear,2 Elisa Berson,3 Shilpa Sridhar,3 Margaret Rote,3 Anthony Hung,3 Subhashini Chandrasekharan4 1Institute for Health and Aging, University of California San Francisco, San Francisco, California, USA, 2Duke Science & ...
Allyse M   +6 more
doaj   +1 more source

Performance Evaluation of Noninvasive Prenatal Testing in Screening Chromosome Disorders: A Single-Center Observational Study of 15,304 Consecutive Cases in China [PDF]

open access: yesInternational Journal of Women's Health
Qiang Ye,1 Guoping Huang,1 Qin Hu,1 Qin Man,2 Xiaoying Hao,3 Liangyan Liu,4 Qiang Zhong,1 Zhao Jin2 1Department of Clinical Laboratory, West China Second University Hospital, Southern Sichuan Women’s and Children’s Hospital, Zigong, Sichuan, 643000 ...
Ye Q   +7 more
doaj   +1 more source

Noninvasive Prenatal Testing Using Fetal Fraction Enrichment—A Pilot Study

open access: yesClinical and Experimental Obstetrics & Gynecology
Background: To evaluate the clinical performance and clinical implementation of noninvasive prenatal testing (NIPT) using fetal fraction (FF) enrichment.
Yun Chen   +8 more
doaj   +2 more sources

Noninvasive prenatal testing for the detection of fetal chromosome 17 microduplication: clinical implications and findings

open access: yesMolecular Cytogenetics
Background  Noninvasive prenatal testing (NIPT) is widely used to screen for fetal aneuploidies. However, there are few reports of using NIPT for screening chromosomal microduplications and microdeletions.
Ye Shi   +5 more
doaj   +2 more sources

The value of NIPT combined with serum cell-free DNA, estriol, AFP, and b-HCG levels in the recognition of trisomy 21 and 18 in the second trimester [PDF]

open access: yesJournal of Medical Biochemistry, 2023
Background: This study aimed to evaluate the clinical application value of noninvasive prenatal testing from DNA (NIPT) and serum screening for screening in detecting fetal trisomy 21 and 18.
Fu JingLi   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy